Back

WINDLAS BIOTECH LIMITED

40/1 MOHABEWALA INDUSTRIAL AREA

Product Categories

Formulations
PANTOPRAZOLE (20 MG),PANTOPRAZOLE (40 MG)
Nutraceuticals
Manufacturers and exporters of finished product formulations

Company Profile

WINDLAS BIOTECH LTD., INDIA, A PUBLICLY LISTED PHARMACEUTICAL CONTRACT MANUFACTURING AND DEVELOPMENT ORGANIZATION. WE ARE CURRENTLY THE THIRD-LARGEST CONTRACT MANUFACTURING COMPANY IN INDIA BY REVENUE, WITH ANNUAL SALES OF APPROXIMATELY USD 100 MILLION, AND WE WORK EXTENSIVELY WITH LEADING MULTINATIONAL AND INDIAN PHARMACEUTICAL COMPANIES. WINDLAS BIOTECH HAS OVER 25 YEARS OF EXPERIENCE IN PHARMACEUTICAL MANUFACTURING AND OPERATES SIX MANUFACTURING SITES. WE ARE ACTIVELY EXPORTING TO CANADA , SOUTH AFRICA AND ARE IN THE PROCESS OF SETTING UP OUR SIXTH MANUFACTURING PLANT THIS YEAR TO SUPPORT FUTURE GROWTH. WE HAVE A STRONG DEVELOPMENT AND CLINICAL CAPABILITY, PARTICULARLY IN CARDIOVASCULAR, DIABETES, UROLOGY, AND GASTROENTEROLOGY SEGMENTS. SEVERAL OF THE FORMULATIONS DEVELOPED FOR INDIA ARE ALSO BEING COMMERCIALIZED BY OUR PARTNERS IN SOUTHEAST ASIAN AND GULF MARKETS. OUR IN-HOUSE REGULATORY TEAM MANAGES END-TO-END APPROVALS WITH RELEVANT GOVERNMENT AUTHORITIES, ENABLING OUR PARTNER